Background
The ASTHMAXcel mobile application has been linked to favorable outcomes among adult patients with asthma.
Objective
We assessed the impact of ASTHMAXcel Adventures, a gamified, guideline-based, pediatric version on asthma control, knowledge, health care utilization, and patient satisfaction.
Methods
Pediatric patients with asthma received the ASTHMAXcel Adventures mobile intervention on-site only at baseline (visit 1), 4 months (visit 2), and 6 months (visit 3). The asthma control test, asthma illness representation scale–self-administered, pediatric asthma impact survey, and Client Satisfaction Questionnaire-8 were used to assess asthma control, knowledge, and patient satisfaction. Patients reported the number of asthma-related emergency department (ED) visits, hospitalizations, and oral prednisone use.
Results
A total of 39 patients completed the study. The proportion of controlled asthma increased from visit 1 to visits 2 and 3 (30.8% vs 53.9%,
P
= .04; 30.8% vs 59.0%,
P
= .02), and largely seen in boys. The mean asthma illness representation scale–self-administered scores increased from baseline pre- to postintervention, with sustained improvements at visits 2 and 3 (3.55 vs 3.76,
P
< .001; 3.55 vs 3.80,
P
= .001; 3.55 vs 3.99,
P
< .001). The pediatric asthma impact survey scores improved from baseline to visits 2 and 3 (43.33 vs 34.08,
P
< .001; 43.33 vs 31.74,
P
< .001). ED visits and prednisone use significantly decreased from baseline to visits 2 and 3 (ED: 0.46 vs 0.13,
P
= .03; 0.46 vs 0.02,
P
= .02; prednisone use, 0.49 vs 0.13,
P
= .02; 0.49 vs 0.03,
P
= .003. Satisfaction was high with mean client satisfaction questionnaire score of approximately 30 (out of 32) at all visits.
Conclusion
ASTHMAXcel Adventures improved asthma control, knowledge, and quality of life, and reduced ED visits and prednisone use with high satisfaction scores.
